About Biscayne Pharma
Biscayne Pharma is a company based in Miami (United States) founded in 2012 was acquired by Supernus Pharmaceuticals in September 2018.. Biscayne Pharma has raised $10.53 million across 5 funding rounds from investors including Supernus Pharmaceuticals, GF Securities and Quark Venture. Biscayne Pharma offers products and services including Health Blogs and Supplements Information.
- Headquarter Miami, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.53 M (USD)
in 5 rounds
-
Latest Funding Round
$3 M (USD), Series B
Jan 27, 2017
-
Investors
Supernus Pharmaceuticals
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Supernus Pharmaceuticals
(Sep 13, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biscayne Pharma
Biscayne Pharma offers a comprehensive portfolio of products and services, including Health Blogs and Supplements Information. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers articles on wellness, meditation, and health tips.
Provides details on supplements like CBD oil and pain relief options.
Funding Insights of Biscayne Pharma
Biscayne Pharma has successfully raised a total of $10.53M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $3.0M
-
First Round
First Round
(21 Jan 2013)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2017 | Amount | Series B - Biscayne Pharma | Valuation |
investors |
|
| Nov, 2015 | Amount | Debt – Conventional - Biscayne Pharma | Valuation |
investors |
|
| Jan, 2015 | Amount | Series A - Biscayne Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biscayne Pharma
Biscayne Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Supernus Pharmaceuticals, GF Securities and Quark Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Provider of investment & asset management and financial services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biscayne Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biscayne Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biscayne Pharma Comparisons
Competitors of Biscayne Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biscayne Pharma
Frequently Asked Questions about Biscayne Pharma
When was Biscayne Pharma founded?
Biscayne Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Biscayne Pharma located?
Biscayne Pharma is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is Biscayne Pharma a funded company?
Biscayne Pharma is a funded company, having raised a total of $10.53M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3.4M, raised on Jan 21, 2013.
What does Biscayne Pharma do?
Biscayne Pharmaceuticals is a clinical stage drug development biotech focusing on CNS disorders (refractory epilepsy) and drug-resistant cancer. Biscayne acquired the CNS program, and the molecule BIS-001, as part of its merger with Insero Health in 2015. BIS-001, which has completed Phase I clinical studies, is an acetylcholinesterase inhibitor. The pipelines for cancer (BIS-1602 - Breast, endometrial, ovarian cancers) and cardiology are based on Growth hormone Releasing Hormone (GHRH) - based on Nobel Laureate Biscayne co-founder, Dr. Andrew Schallys research.
What products or services does Biscayne Pharma offer?
Biscayne Pharma offers Health Blogs and Supplements Information.
Who are Biscayne Pharma's investors?
Biscayne Pharma has 5 investors. Key investors include Supernus Pharmaceuticals, GF Securities, Quark Venture, Mesa Verde Venture Partners, and Florida Institute.